“Modern living, environmental factors and viral activation can leave many people with immune system pressures which may contribute to long-term health challenges. Micro-Immunotherapy offers a cutting-edge approach to precisely assess support immune communication and balance.”
The immune system does so much more than defend against infections—it regulates inflammation, supports digestion, and even influences mood and mental clarity. Its proper functioning is essential for overall health and it plays a key role in almost every disease process.
Micro-Immunotherapy (MIT) uses low and ultra-low doses of plant-derived substances designed to interact with immune signalling pathways. Developed over 50 years ago by Belgian doctor Maurice Jenaer, MIT is gaining global popularity as scientific studies continue to validate its efficacy.
MIT uses a precise, personalised protocol of specialised substances with immunoregulatory properties, taken to gentle support immune balance over time. These substances reach the immune system through the lymphatic system—delivering safe messengers that mimic the body’s natural immune communication.
Dr. Forbes is one of the few doctors in the UK trained to deliver this transformative therapy.
Micro-Immunotherapy (MIT) aims to gently support immune regulation over time. A typical remedy protocol takes 10–12 months and is usually divided into two phases, focusing on:
Your remedy protocol will be developed based on a detailed medical history and advanced blood testing which evaluates:
In some cases, particularly for young children or individuals undergoing chemotherapy or taking steroids, blood testing may be skipped, and clinical context will guide the treatment approach.
If you'd like to track the effectiveness of the therapy, additional tests can be done before starting and repeated as you progress. MIT is a gentle, non-invasive approach suitable for adults and children.
Dr Anna Forbes is a respected Integrative Medicine Doctor with a special interest in the Immune System, gut health and auto-immune disease. She offers Micro-Immunotherapy by professional referral, as a standalone service or as part of a full Integrative Health Plan following Integrative Health Assessment.
Includes:
The T Helper Cell Typing and Inflammation Profile tests are recommended at the start of your MIT programme to establish a baseline. They can then be repeated at key stages — typically around the 6 and 12 month mark — to measure how your immune system is responding over time.
Special Interests:
Gut & Skin Health, Immune Conditions, Allergy & Intolerances, Detoxification, Child Health, Fatigue, Cancer, Mind-Body Medicine.
Having qualified from Nottingham University in 2006, Dr Anna Forbes was a GMC-licensed doctor for 20 years. In April 2026, she voluntarily relinquished her GMC license to be able to concentrate on 21st Century Integrative Medicine. She continues to work in close collaboration with the other doctors at the clinic, who remain GMC-registered.
Dr Forbes takes a holistic approach that combines cutting-edge medical science with advanced nutritional, psycho-emotional, and spiritual approaches to health. She supports clients in exploring the underlying factors influencing their wellbeing and creating a path towards optimal health.
Dr Forbes was GMC-licensed for 20 years. In May 2026, she voluntarily relinquished her GMC licence to enable her to practise Integrative Medicine more authentically and expansively. She continues to lead The Forbes Clinic and practise as an Integrative Medicine Doctor.
Micro-immunotherapy formulas always need to be taken in the sequential order from 1-10. Inside the box you will find 3 blister packs. Choose one to start, all three are identical.
Take the first capsule, marked with number 1, and follow the numeric sequence with each intake.
Once a blister pack is finished, move on to capsule 1 from the next blister pack and so on.
You should allow at least 2 hours between the different intakes of remedies if you have more than one on your protocol.
Your capsules should not be swallowed. Hold the capsule with the head upwards and carefully open it by pulling its head.
Pour the content of the capsule under the tongue and let it dissolve. When taking Micro-immunotherapy remedies you should not eat or drink from about 20 minutes before until 20 minutes after the intake. This is to ensure a good absorption of the remedies through the mouth mucosa, which needs to be clean and receptive for this purpose.
The capsules containing the granules are designed to be dissolved under the tongue. Nevertheless, they pose no threat to health as they are identical to those of medicines intended to be swallowed.
If you are taking more than one remedy in your recommended protocol, the different capsules should NOT be taken together. You should allow at least 2 hours between each intake.
For example, if you take two remedies: take the first capsule of Remedy A right after getting up, before breakfast. Take the first capsule of Remedy B at least 2 hours later. Take the second capsule of Remedy A at least 2 hours after that, and finally the second capsule of Remedy B at least 2 hours after that.
If you're taking four remedies, the same principle applies, just extended across the day: take the first capsule right after waking, before breakfast, then space each of the remaining three capsules at least 2 hours apart. For example, if you wake at 7:00 AM, this might look like: Remedy A at 7:00 AM, Remedy B at 9:00 AM, Remedy C at 11:00 AM, and Remedy D at 1:00 PM.
Whatever time you wake up, simply shift this timeline forward and keep each intake at least 2 hours apart. With four remedies, you'll need a minimum 6-hour window from your first capsule to your last, so it helps to start soon after waking — especially since (aside from SLEEPREG) remedies shouldn't be taken after 6:00 PM.
Your other regular supplements can be taken at a time of your convenience in between.
The recommendation not to take Micro-immunotherapy remedies after 06:00 PM (except SLEEPREG, which needs to be taken before going to bed) refers to the biological rhythm of the immune system which is reduced towards night time and is also aiming not to disturb the patients sleep. In very rare cases, patients who have taken their remedies later have reported difficulties falling asleep afterwards. In summary: it's a question of biological rhythm.
The components within the remedies are immune messenger substances, consisting of low and ultra-low dose plant cytokines. All of these substances are of plant origin.
The remedies contain tiny amounts of lactose. This is fine for someone with lactose intolerance, but not suitable for anyone with a serious lactose allergy.
Micro-immunotherapy can be combined with all kinds of medical treatments, both classical and from the field of integrative medicine.
Micro-immunotherapy formulas are used together with nutritional supplements on a regular basis and with great success.
When combining Micro immunotherapy and nutritional supplements (as with all other combinations) both approaches should follow the same overall therapeutic objective (i.e. not combining immune-boosting Micro immunotherapy formulas with anti-inflammatory nutritional supplements.)
After your MIT Protocol Consult with Dr Forbes a member of the team will be in touch to confirm the remedies that have been recommended. If you choose to go ahead, you will receive an invoice via Practice Better. Once paid a member of the team will place an order with Biomedico, our supplier.
Biomedico dispatches orders to the UK once a week, every Thursday. Orders need to be placed with the team before Wednesday lunchtime.
Deliveries are sent via Royal Mail Tracked and usually arrive with clients on a Friday. Shipping is £20 per delivery.
If you are looking to have your remedies delivered to an address outside of the UK, please reach out to MIT@theforbesclinic.co.uk to receive a shipping quote.
Micro Immunotherapy is most effective when you you also address any environmental, biochemical, physiological and dietary factors that might be contributing to your symptoms. Our Integrative Health Assessment and multi-disciplinary health plans take a whole-person approach to health and wellbeing synthesising the best available approaches from medical science, traditional practices and specialised treatments and therapies to get to the root-cause of your health concern. Book with Dr Forbes for a Integrative Health Plan that utilises Micro-Immunotherapy.
Floris, I., García-González, V., Palomares, B., Appel, K. & Lejeune, B. (2020). The Micro-Immunotherapy Medicine 2LARTH® Reduces Inflammation and Symptoms of Rheumatoid Arthritis In Vivo. International Journal of Rheumatology, 2020, 1594573. https://doi.org/10.1155/2020/1594573 Accessed 05/04/2025.
Jacques, C., Marchand, F., Chatelais, M. & Floris, I., 2024. Actives from the Micro-Immunotherapy Medicine 2LMIREG® Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial Function. Journal of Inflammation Research, 17, pp.1161-1181. Available at: https://www.dovepress.com/actives-from-the-micro-immunotherapy-medicine-2lmireg-reduce-the-expre-peer-reviewed-fulltext-article-JIR [Accessed 6 Apr. 2025]. DOI: 10.2147/JIR.S445053
Mancini, F., Milardi, D., Carfagna, P., Grande, G., Miranda, V., De Cicco Nardone, A., Ricciardi, D., Pontecorvi, A., Marana, R. & De Cicco Nardone, F., 2018. Low-dose SKA Progesterone and Interleukin-10 modulate the inflammatory pathway in endometriotic cell lines. International Immunopharmacology, 55, pp.223-230. DOI: 10.1016/J.INTIMP.2017.12.008.
Lilli, N.R., Révy, D., Robelet, S. & Lejeune, B., 2019. Effect of the micro-immunotherapy medicine 2LPARK® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson's disease. Degenerative Neurological and Neuromuscular Disease, 9, pp.79-88. Available at: https://pubmed.ncbi.nlm.nih.gov/31372089/ [Accessed 6 Apr. 2025]. DOI: 10.2147/DNND.S202966
D’Amico, L., Ruffini, E., Ferracini, R. & Roato, I., 2012. Low Dose of IL-12 Stimulates T Cell Response in Cultures of PBMCs Derived from Non Small Cell Lung Cancer Patients. Journal of Cancer Therapy, 3(4), pp.337-342. DOI: 10.4236/JCT.2012.324044.
